Cite
HARVARD Citation
Phan, U. et al. (n.d.). Development of the anti-IL-10 mAb MK-1966 in combination with in situ vaccination of a TLR9 agonist SD-101 for cancer immunotherapy. European journal of cancer. pp. S91-S92. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Phan, U. et al. (n.d.). Development of the anti-IL-10 mAb MK-1966 in combination with in situ vaccination of a TLR9 agonist SD-101 for cancer immunotherapy. European journal of cancer. pp. S91-S92. [Online].